Peter Salaj

1.1k total citations · 1 hit paper
49 papers, 719 citations indexed

About

Peter Salaj is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Peter Salaj has authored 49 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Hematology, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Genetics. Recurrent topics in Peter Salaj's work include Platelet Disorders and Treatments (16 papers), Hemophilia Treatment and Research (15 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Peter Salaj is often cited by papers focused on Platelet Disorders and Treatments (16 papers), Hemophilia Treatment and Research (15 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Peter Salaj collaborates with scholars based in Czechia, Sweden and France. Peter Salaj's co-authors include Jiřı́ Suttnar, Jan E. Dyr, Víctor Jiménez‐Yuste, T Binder, Tomáš Zima, Libor Vı́tek, Jerome Teitel, Peter W. Collins, Andreas Tiede and Paul Giangrande and has published in prestigious journals such as Blood, International Journal of Molecular Sciences and Critical Care.

In The Last Decade

Peter Salaj

44 papers receiving 694 citations

Hit Papers

International recommendations on the diagnosis and treatm... 2020 2026 2022 2024 2020 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. International recommendations on the diagnosis and treatment of acquired hemophilia A
    2020 183 citations Andreas Tiede, Peter W. Collins et al. Haematologica profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Salaj Czechia 15 509 139 136 94 70 49 719
Stefano Mancini Italy 9 155 0.3× 105 0.8× 136 1.0× 60 0.6× 60 0.9× 27 419
Kenichi Ogiwara Japan 20 855 1.7× 229 1.6× 106 0.8× 116 1.2× 16 0.2× 95 1.1k
R. Grace United Kingdom 8 147 0.3× 52 0.4× 106 0.8× 53 0.6× 68 1.0× 17 352
Elena Pérez‐Ceballos Spain 13 236 0.5× 180 1.3× 28 0.2× 63 0.7× 107 1.5× 25 578
Roswitha Dickerhoff Germany 12 245 0.5× 96 0.7× 58 0.4× 174 1.9× 114 1.6× 37 556
Barbara Eifrig Germany 13 285 0.6× 78 0.6× 38 0.3× 28 0.3× 51 0.7× 23 416
Yeu‐Chin Chen Taiwan 11 136 0.3× 46 0.3× 84 0.6× 34 0.4× 51 0.7× 55 313
Ayhan Dönmez Türkiye 10 177 0.3× 66 0.5× 63 0.5× 35 0.4× 77 1.1× 40 382
Geerte L. Van Sluis Netherlands 7 166 0.3× 56 0.4× 88 0.6× 67 0.7× 61 0.9× 11 438
Neil Goldsack United Kingdom 7 101 0.2× 53 0.4× 103 0.8× 365 3.9× 29 0.4× 9 657

Countries citing papers authored by Peter Salaj

Since Specialization
Citations

This map shows the geographic impact of Peter Salaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Salaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Salaj more than expected).

Fields of papers citing papers by Peter Salaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Salaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Salaj. The network helps show where Peter Salaj may publish in the future.

Co-authorship network of co-authors of Peter Salaj

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Salaj. A scholar is included among the top collaborators of Peter Salaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Salaj. Peter Salaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Salaj, Peter, et al.. (2021). Hereditary antithrombin deficiency in pregnancy – severe thrombophilic disorder as a danger for mother and foetus. PubMed. 86(3). 175–182. 1 indexed citations
2.
Tiede, Andreas, Peter W. Collins, Paul Knoebl, et al.. (2020). International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 105(7). 1791–1801. 183 indexed citations breakdown →
3.
Salaj, Peter, et al.. (2018). Range of motion after total knee arthroplasty in hemophilic arthropathy. BMC Musculoskeletal Disorders. 19(1). 162–162. 16 indexed citations
4.
Sørensen, Benny, Günter Auerswald, Gary Benson, et al.. (2014). Rationale for individualizing haemophilia care. Blood Coagulation & Fibrinolysis. 26(8). 849–857. 17 indexed citations
5.
Kotlín, Roman, et al.. (2014). Two novel mutations in the fibrinogen γ nodule. Thrombosis Research. 134(4). 901–908. 5 indexed citations
6.
Salaj, Peter, Petr Cetkovský, Miroslav Penka, et al.. (2013). Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry. Thrombosis Research. 133(2). 162–167. 5 indexed citations
7.
8.
Kotlín, Roman, Zuzana Reicheltová, Jiřı́ Suttnar, et al.. (2010). Two novel fibrinogen variants in the C-terminus of the Bβ-chain: fibrinogen Rokycany and fibrinogen Znojmo. Journal of Thrombosis and Thrombolysis. 30(3). 311–318. 12 indexed citations
9.
Reicheltová, Zuzana, Martin Malý, Jiřı́ Suttnar, et al.. (2009). Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň. Thrombosis and Haemostasis. 102(9). 479–486. 15 indexed citations
10.
11.
Kotlín, Roman, Tomáš Riedel, Peter Salaj, et al.. (2008). Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematologica. 120(2). 75–81. 28 indexed citations
12.
Kotlín, Roman, et al.. (2008). High-resolution melting analysis for detection of MYH9 mutations. Platelets. 19(6). 471–475. 6 indexed citations
13.
Malý, Martin, Ingrid Hrachovinová, Pavol Tomašov, et al.. (2008). Patients with acute coronary syndromes have low tissue factor activity and microparticle count, but normal concentration of tissue factor antigen in platelet free plasma – a pilot study. European Journal Of Haematology. 82(2). 148–153. 10 indexed citations
14.
Kotlín, Roman, Jiřı́ Suttnar, Peter Salaj, et al.. (2008). A novel fibrinogen variant – Liberec: dysfibrinogenaemia associated with γ Tyr262Cys substitution. European Journal Of Haematology. 81(2). 123–129. 9 indexed citations
15.
Tomašov, Pavol, et al.. (2007). The role of tissue factor in thrombosis and hemostasis. Physiological Research. 56(6). 685–695. 14 indexed citations
16.
Kotlín, Roman, Jiřı́ Suttnar, Tomáš Riedel, et al.. (2007). Fibrinogen Nový Jičín and Praha II: Cases of hereditary Aα 16 Arg→Cys and Aα 16 Arg→His dysfibrinogenemia. Thrombosis Research. 121(1). 75–84. 19 indexed citations
17.
Binder, T, Peter Salaj, & Tomáš Zima. (2007). [Intrahepatic cholestasis in pregnancy--guidelines of treatment].. PubMed. 72(2). 94–8. 2 indexed citations
18.
Binder, T, Peter Salaj, Tomáš Zima, & Libor Vı́tek. (2006). Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. Journal of Perinatal Medicine. 34(5). 383–91. 63 indexed citations
19.
Malý, Martin, et al.. (2003). Tissue factor, tissue factor pathway inhibitor and cytoadhesive molecules in patients with an acute coronary syndrome.. Physiological Research. 52(6). 719–728. 24 indexed citations
20.
Suttnar, Jiřı́, et al.. (2002). [Effect of oxidized cellulose on fibrin formation and blood platelets].. PubMed. 141 Suppl. 50–3. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stefano Mancini Breakdown of academic impact, for papers by Kenichi Ogiwara Breakdown of academic impact, for papers by R. Grace Breakdown of academic impact, for papers by Elena Pérez‐Ceballos Breakdown of academic impact, for papers by Roswitha Dickerhoff Breakdown of academic impact, for papers by Barbara Eifrig Breakdown of academic impact, for papers by Yeu‐Chin Chen Breakdown of academic impact, for papers by Ayhan Dönmez Breakdown of academic impact, for papers by Geerte L. Van Sluis Breakdown of academic impact, for papers by Neil Goldsack
Rankless by CCL
2026